{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:38:21Z","timestamp":1790120301085,"version":"4.0.1"},"reference-count":41,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,3,15]]},"DOI":"10.2169\/internalmedicine.8113-21","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T22:08:58Z","timestamp":1630706938000},"page":"801-810","source":"Crossref","is-referenced-by-count":8,"title":["Characteristics of Ischemic Versus Hemorrhagic Stroke in Patients Receiving Oral Anticoagulants: Results of the PASTA Study"],"prefix":"10.2169","volume":"61","author":[{"given":"Satoshi","family":"Suda","sequence":"first","affiliation":[{"name":"Department of Neurology, Nippon Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arata","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Neurology and Stroke Medicine, Tokyo Metropolitan Tama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Iguchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Jikei University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Yagita","sequence":"additional","affiliation":[{"name":"Department of Stroke Medicine, Kawasaki Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Kanzawa","sequence":"additional","affiliation":[{"name":"Department of Stroke Medicine, Institute of Brain and Blood Vessels, Mihara Memorial Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Okubo","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, NTT Medical Center Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Ohara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Mizunari","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nippon Medical School Chiba Hokusoh Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineo","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nippon Medical School Chiba Hokusoh Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhito","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kitamurayama Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimito","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hokuto Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, Jichi Medical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Stroke Medicine, Kawasaki Medical School General Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Iwanaga","sequence":"additional","affiliation":[{"name":"Department of Stroke Medicine, Japanese Red Cross Okayama Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Terasawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brain Attack Center Ota Memorial Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensaku","family":"Shibazaki","sequence":"additional","affiliation":[{"name":"Department of Stroke Medicine, Kurashiki Heisei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fuji City General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Neurology, Heisei-Tateishi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Mishina","sequence":"additional","affiliation":[{"name":"Department of Neuro-pathophysiological Imaging, Graduate School of Medicine, Nippon Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Adachi","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Nippon Medical School Musashi-Kosugi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Imafuku","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yokohama Rosai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shioda Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Nagao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nippon Medical School Tama Nagayama Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yaguchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Jikei University Kashiwa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadahisa","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Omuta Tenryo Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Osaki","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, Steel Memorial Yawata Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nippon Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Akao M, Chun YH, Wada H, et al. Current status of clinical background of patients with atrial fibrillation in a community-based survey: the Fushimi AF Registry. J Cardiol 61: 260-266, 2013.","DOI":"10.1016\/j.jjcc.2012.12.002"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Iguchi Y, Kimura K, Aoki J, et al. Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city. Circ J 72: 909-913, 2008.","DOI":"10.1253\/circj.72.909"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kimura K, Minematsu K, Yamaguchi T; Japan Multicenter Stroke Investigators C. Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry 76: 679-683, 2005.","DOI":"10.1136\/jnnp.2004.048827"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 115: 2689-2696, 2007.","DOI":"10.1161\/CIRCULATIONAHA.106.653048"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383: 955-962, 2014.","DOI":"10.1016\/S0140-6736(13)62343-0"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Caldeira D, Rodrigues FB, Barra M, et al. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis. Heart 101: 1204-1211, 2015.","DOI":"10.1136\/heartjnl-2015-307489"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Senoo K, Lau YC, Dzeshka M, Lane D, Okumura K, Lip GY. Efficacy and safety of non-vitamin K antagonist oral anticoagulants vs. warfarin in Japanese patients with atrial fibrillation - meta-analysis. Circ J 79: 339-345, 2015.","DOI":"10.1253\/circj.CJ-14-1042"},{"key":"8","unstructured":"8. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J 42: 373-498, 2021."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. January CT, Wann LS, Calkins H, et al. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons. Circulation 140: e125-e151, 2019.","DOI":"10.1161\/CIR.0000000000000665"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Toyoda K, Arihiro S, Todo K, et al. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study. Int J Stroke 10: 836-842, 2015.","DOI":"10.1111\/ijs.12452"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Lip GYH, Lane DA, Buller H, Apostolakis S. Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS study. Chest 144: 1839-1847, 2013.","DOI":"10.1378\/chest.13-1635"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Okumura Y. What scoring system should we use to assess bleeding risk in atrial fibrillation? Circ J 80: 2089-2091, 2016.","DOI":"10.1253\/circj.CJ-16-0855"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Maruhashi T, Higashi Y. Antithrombotic therapy for stroke prevention in patients with atrial fibrillation in Japan. Expert Opin Pharmacother 21: 2115-2124, 2020.","DOI":"10.1080\/14656566.2020.1799976"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Takahashi H, Jimbo Y, Takano H, et al. Intracerebral hematoma occurring during warfarin versus non-vitamin K antagonist oral anticoagulant therapy. Am J Cardiol 118: 222-225, 2016.","DOI":"10.1016\/j.amjcard.2016.04.034"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Auer E, Frey S, Kaesmacher J, et al. Stroke severity in patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists. J Neurol 266: 2263-2272, 2019.","DOI":"10.1007\/s00415-019-09412-y"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sakamoto Y, Okubo S, Nito C, et al. The relationship between stroke severity and prior direct oral anticoagulant therapy in patients with acute ischaemic stroke and non-valvular atrial fibrillation. Eur J Neurol 24: 1399-1406, 2017.","DOI":"10.1111\/ene.13405"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kawabori M, Niiya Y, Iwasaki M, et al. Characteristics of symptomatic intracerebral hemorrhage in patient receiving direct oral anticoagulants: comparison with warfarin. J Stroke Cerebrovasc Dis 27: 1338-1342, 2018.","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.12.020"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Suda S, Aoki J, Shimoyama T, et al. Characteristics of acute spontaneous intracerebral hemorrhage in patients receiving oral anticoagulants. J Stroke Cerebrovasc Dis 28: 1007-1014, 2019.","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.013"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Suda S, Iguchi Y, Fujimoto S, et al. Multicenter prospective analysis of stroke patients taking oral anticoagulants: the PASTA registry - study design and characteristics. J Stroke Cerebrovasc Dis 28: 104456, 2019.","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104456"},{"key":"20","unstructured":"20. Camm AJ, Kirchhof P, Lip GY, et al.; European Heart Rhythm; European Association for Cardio-Thoracic S. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31: 2369-2429, 2010."},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138: 1093-1100, 2010.","DOI":"10.1378\/chest.10-0134"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hamatani Y, Nagai T, Nakai M, et al. Elevated plasma D-dimer level is associated with short-term risk of ischemic stroke in patients with acute heart failure. Stroke 49: 1737-1740, 2018.","DOI":"10.1161\/STROKEAHA.118.021899"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yoshimuta T, Yokoyama H, Okajima T, et al. Impact of elevated D-dimer on diagnosis of acute aortic dissection with isolated neurological symptoms in ischemic stroke. Circ J 79: 1841-1845, 2015.","DOI":"10.1253\/circj.CJ-15-0050"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ohara T, Koga M, Tokuda N, et al. Rapid identification of type A aortic dissection as a cause of acute ischemic stroke. J Stroke Cerebrovasc Dis 25: 1901-1906, 2016.","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.04.005"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18: 891-975, 2016.","DOI":"10.1002\/ejhf.592"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Todo K, Iwata T, Doijiri R, et al. Frequent premature atrial contractions in cryptogenic stroke predict atrial fibrillation detection with insertable cardiac monitoring. Cerebrovasc Dis 49: 144-150, 2020.","DOI":"10.1159\/000505958"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Suda S, Shimoyama T, Suzuki S, et al. Prevalence and clinical characteristics of cortical superficial siderosis in patients with acute stroke. J Neurol 264: 2413-2419, 2017.","DOI":"10.1007\/s00415-017-8646-1"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Wilson D, Charidimou A, Ambler G, et al. Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: a meta-analysis. Neurology 87: 1501-1510, 2016.","DOI":"10.1212\/WNL.0000000000003183"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Hagii J, Tomita H, Metoki N, et al. Characteristics of intracerebral hemorrhage during rivaroxaban treatment: comparison with those during warfarin. Stroke 45: 2805-2807, 2014.","DOI":"10.1161\/STROKEAHA.114.006661"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Choi KH, Seo WK, Park MS, et al. Baseline D-dimer levels as a risk assessment biomarker for recurrent stroke in patients with combined atrial fibrillation and atherosclerosis. J Clin Med 8: 2019.","DOI":"10.3390\/jcm8091457"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Siegbahn A, Oldgren J, Andersson U, et al. D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy. Thromb Haemost 115: 921-930, 2016.","DOI":"10.1160\/TH15-07-0529"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Christersson C, Wallentin L, Andersson U, et al. D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial. J Thromb Haemost 12: 1401-1412, 2014.","DOI":"10.1111\/jth.12638"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Llombart V, Antolin-Fontes A, Bustamante A, et al. B-type natriuretic peptides help in cardioembolic stroke diagnosis: pooled data meta-analysis. Stroke 46: 1187-1195, 2015.","DOI":"10.1161\/STROKEAHA.114.008311"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Shibazaki K, Kimura K, Okada Y, Iguchi Y, Terasawa Y, Aoki J. Heart failure may be associated with the onset of ischemic stroke with atrial fibrillation: a brain natriuretic peptide study. J Neurol Sci 281: 55-57, 2009.","DOI":"10.1016\/j.jns.2009.02.374"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Rieder MJ, Reiner AP, Gage BF, et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 352: 2285-2293, 2005.","DOI":"10.1056\/NEJMoa044503"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Takahashi H, Wilkinson GR, Caraco Y, et al. Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients. Clin Pharmacol Ther 73: 253-263, 2003.","DOI":"10.1067\/mcp.2003.26a"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Shen AY, Yao JF, Brar SS, Jorgensen MB, Chen W. Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol 50: 309-315, 2007.","DOI":"10.1016\/j.jacc.2007.01.098"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Shinohara Y. For readers (stroke specialists and general practitioners) of the Japanese guidelines for the management of stroke. Preface. J Stroke Cerebrovasc Dis 20: S1-S6, 2011.","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.05.002"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Yasaka M, Minematsu K, Yamaguchi T. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med 40: 1183-1188, 2001.","DOI":"10.2169\/internalmedicine.40.1183"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40. Charidimou A, Kakar P, Fox Z, Werring DJ. Cerebral microbleeds and recurrent stroke risk: systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts. Stroke 44: 995-1001, 2013.","DOI":"10.1161\/STROKEAHA.111.000038"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Narita N, Okumura K, Kinjo T, et al. Trends in prevalence of non-valvular atrial fibrillation and anticoagulation therapy in a japanese region - analysis using the national health insurance database. Circ J 84: 706-713, 2020.","DOI":"10.1253\/circj.CJ-18-0989"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/6\/61_8113-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T03:32:20Z","timestamp":1647660740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/6\/61_8113-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8113-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"article-number":"8113-21"}}